French Pharma Giant Expands China Cancer Drug Partnership
Pierre Fabre Laboratories partners with Sinopharm to boost cancer drug production in China, aligning with the country’s 2026-2030 economic plan.
CancerResearch
Read More
Australian Trial Targets ‘Undruggable’ Cancers with New Molecular Approach
Australian researchers launch a groundbreaking clinical trial targeting MYC-driven cancers using a novel molecular approach, offering hope for untreatable malignancies globally.
Cancer Dormancy Breakthrough Sparks Hope for New Treatments
Israeli researchers uncover how breast cancer cells lie dormant, offering potential pathways to prevent recurrence and develop new treatments.
Chinese Scientists Uncover Cancer’s Immune Evasion Tactic: Arginine Abuse
Chinese researchers uncover how breast cancer tumors weaponize arginine to sabotage immune responses, revealing new paths for combination cancer therapies.
Chinese Scientists Find Natural Cancer Fighter in Breakthrough Liver Study
Chinese scientists discover a natural compound from traditional medicine that blocks cancer cell energy transport, offering new liver cancer treatment potential.
Chinese AI Breakthrough Predicts Liver Cancer Recurrence with 82% Accuracy
Chinese scientists unveil AI tool predicting liver cancer recurrence with 82% accuracy, offering new hope for global oncology care.
China’s Ivonescimab Outperforms Keytruda in Late-Stage Cancer Trials
Chinese-developed cancer drug Ivonescimab surpasses Keytruda in Phase III trials, signaling potential shift in global oncology treatment standards.